Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

Mantle cell lymphoma (MCL) is still considered incurable and the course of the disease is highly variable. Established risk factors include the Mantle Cell Lymphoma International Prognostic Index (MIPI) and the quantification of the proliferation rate of the tumour cells, e.g. by Ki-67 immunohistoch...

詳細記述

保存先:
書誌詳細
出版年:Br J Haematol
主要な著者: Rauert-Wunderlich, Hilka, Mottok, Anja, Scott, David W., Rimsza, Lisa M., Ott, German, Klapper, Wolfram, Unterhalt, Michael, Kluin-Nelemans, Hanneke C., Hermine, Olivier, Hartmann, Sylvia, Thorns, Christoph, Rymkiewicz, Grzegorz, Holte, Harald, Dreyling, Martin, Hoster, Eva, Rosenwald, Andreas
フォーマット: Artigo
言語:Inglês
出版事項: 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6361690/
https://ncbi.nlm.nih.gov/pubmed/30095158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15519
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料